Latest / Washington DC News Today | 2 Min News | The Daily News Now!
Vitruvias Thyroid Recall Alert | Washington DC News
Vitruvias Therapeutics is recalling one specific batch of their USP 30mg Thyroid Tablets due to potential overpotency, which could lead to dangerous hyperthyroidism symptoms like unexplained weight loss, muscle weakness, and chest pain—especially risky for the elderly, babies, and pregnant women. The affected lot (504950) was shipped between Jan 31, 2025, and Sept 30, 2025, and expires Sept 30, 2026. No adverse reactions have been reported yet, but patients should NOT stop taking their meds without consulting a doctor. Contact Vitruvias at safety@vitruvias.com or 256-239-9373, or report…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.